| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phibro Animal Health Corporation (PAHC) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. PAHC is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 56.2K | $1.79M | - | |
| Dir | 41.5K | $1.32M | +10.0K | |
| COO | 35.2K | $1.12M | - | |
| CFO | 34.8K | $1.11M | - | |
| VP | 4.0K | $126.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2017 | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sale+OE | 7,681 | $40.04 | $307,573.67 | -100% | |
| Jul 6, 2017 | Bendheim Jack49 | President And CEO | Sell | 32,000 | $36.49 | $1,167,680.00 | -44.4% | |
| Jul 6, 2017 | Bfi Co., LLC | 10% Owner | Sell | 32,000 | $36.49 | $1,167,680.00 | -44.4% | |
| Jun 30, 2017 | Bendheim Jack49 | President And CEO | Sell | 48,000 | $37.42 | $1,796,286.00 | -16.7% | |
| Jun 30, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $37.42 | $1,796,286.00 | -16.7% | |
| Jun 23, 2017 | Bendheim Jack49 | President And CEO | Sell | 48,000 | $37.15 | $1,783,360.00 | -20.0% | |
| Jun 23, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $37.15 | $1,783,360.00 | -20.0% | |
| Jun 15, 2017 | Bendheim Jack49 | President And CEO | Sell | 48,000 | $34.82 | $1,671,518.15 | -15.8% | |
| Jun 15, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $34.82 | $1,671,518.15 | -15.8% | |
| Jun 9, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $35.62 | $1,709,920.00 | -20.0% |